Safety and Efficacy of AGN201781 in Neuropathic Pain

Study Identifier
201781-504
CT.gov Identifier
NCT00533351
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Other
Sign up for trial alerts

Study Details

Medical Condition
  • Pain
    • Study Drug
  • AGN201781
  • placebo
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 80 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of postherpetic neuralgia or post-traumatic peripheral neuralgia * Moderate or severe pain associated with postherpetic neuralgia or post-traumatic peripheral neuralgia
    Exclusion Criteria:
    * Women of child-bearing potential * Any other uncontrolled diseases

    Protocol Summary

    This study will explore the safety and efficacy of AGN201781 in patients with postherpetic neuralgia or post-traumatic peripheral neuralgia

    Study Locations

    Location
    Status
    Location
    St Leonards, New South Wales, Australia
    Status
    Not applicable
    Location
    Kiel, Germany
    Status
    Not applicable